ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Zydus Cadila receives final approval from USFDA for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets
July 05, 2021Zydus Cadila has received final approval from the USFDA to market Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 100 mg/150 mg, 133 mg/200 mg and 167 mg/250 mg, a company statement said. -
Lupin gets USFDA nod to market generic HIV drug
June 08, 2021The company has received approval from the United States Food and Drug Administration (USFDA) to market its emtricitabine and tenofovir disoproxil fumarate tablets, 200 mg/300 mg, Lupin said in a regulatory filing. -
Strides gets USFDA approval for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets
January 15, 2021The combination of Emtricitabine and Tenofovir slows down the spread of HIV in the body and is used along with other medications to treat HIV in adults and children.
Pharma Sources Insight January 2025
